NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Fullife Healthcare Raises ₹300 Crore in Series D Funding

Fullife Healthcare, a consumer health and wellness brand operating under the brands Fast&Up and Chicnutrix, has secured ₹300 crore in a series D funding round from Elev8 Venture Partners and its limited partners. This investment marks Elev8's first foray into the Direct-to-Consumer (D2C) space.

The fresh capital will be utilized by Fullife Healthcare to strengthen its brands, expand its product portfolio, and scale its manufacturing capabilities. The company aims to build a global Fast-Moving Health & Wellness Goods (FMHG) company that is proudly made in India, for India, and built for the world. Fullife Healthcare has been profitable and is poised for sustained growth, driven by its strong brand presence and deep understanding of evolving consumer requirements.

Fullife Healthcare has an existing portfolio that spans hydration, weight management, and beauty nutrition. The company plans to expand into high-growth segments such as digestive health, sleep support, and protein-based nutrition, further strengthening its presence in the broader health and wellness ecosystem. Founded in 2011, Fullife Healthcare is among India's largest manufacturers in the effervescent formats category.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

The investment highlights a strategic expansion into consumer platforms, with a strong focus on brands leveraging science, innovation, and digital channels to tap into large and evolving consumer markets. Avendus Capital acted as the exclusive financial advisor to Fullife Healthcare and its shareholders on this transaction.

Key Highlights:

  • ₹300 crore in series D funding from Elev8 Venture Partners and its limited partners
  • Investment marks Elev8's first foray into the D2C space
  • Fullife Healthcare aims to build a global FMHG company
  • Plans to expand into high-growth segments such as digestive health, sleep support, and protein-based nutrition
  • Founded in 2011, Fullife Healthcare is among India's largest manufacturers in the effervescent formats category

Investor Takeaway

Investors should consider Fullife Healthcare's growth potential in the FMCG sector.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.